ArticleSage open pediatrics
The Incidence and 5-Years Relative Survival Rate of Cancer Among People Younger Than 25 Years in the US, 2000 to 2020: A SEER-Retrospective Study and Fertility Preservation Considerations.
Article in Sage open pediatrics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Risk factors for postoperative recurrence of thyroid cancer patients in children, adolescents, and young adults.Translational pediatrics · 2026Article
- Design, synthesis and antiproliferative, apoptotic, and immunomodulatory properties of new heteroaryl pyridine-linked 1,2,4-oxadiazoles as prospective dual EGFR/BRAFRSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To report the incidence and survival patterns for children, adolescents, and young adults (CAYA) cancer survivors over the past 20 years. Methods: CAYA (under 25 years old) cancer survivors from 17 Surveillance, Epidemiology, and End Results (SEER) registries from 2000 to 2020 were analyzed. A joinpoint regression model was used to analyze the incidence and 5-year survival rate. Results: The overall age-standardized cancer incidence (ASIR) of CAYA cancer was 19.26 per 100 000 in 2000 and 21.47 per 100 000 in 2020 in SEER17. The incidence rate of CAYA cancer increased over time. The most common cancer types were leukemia, lymphoma, brain and other nervous system, endocrine system, and male genital system cancer, accounting for over 60% of CAYA cancer cases. The 5-year relative survival rate of CAYA increased from 80.40% in 2000 to 87.80% in 2015. Conclusions: There were more CAYA cancer survivors at risk of long-term sequelae.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.